Author:
Babaei Nasib,Zamanzadeh Vahid,Pourabbasi Maryam,Avazeh Marziyeh,Shokoufamanesh Ayoub
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Rawla P, Barsouk A (2019) Epidemiology of gastric cancer: global trends, risk factors and prevention. Gastroenterol Rev/Prz Gastroenterol 14(1):26–38
2. World Health Organization “International Agency for Research on Cancer”. Globocan 2020: stomach. Available online: https://gco.iarc.fr/today/data/factsheets/cancers/7-Stomach-fact-sheet.pdf. Accessed 9 Jan 2023
3. Hu M, Qian C, Hu Z, Fei B, Zhou H (2017) Biomarkers in tumor microenvironment? Upregulation of fibroblast activation protein-α correlates with gastric cancer progression and poor prognosis. Omics: J Integr Biol 21(1):38–44
4. Rezvani H, Atarian H, Ghadyani M, Abasahl AG (2008) Eloxatin (oxaliplatin), xeloda (capecitabine) and epirubicin (EXE) as first line treatment in metastatic gastric carcinoma. Iran J Surg 16(3):26–32
5. Merchant SJ, Kong W, Brundage M, Booth CM (2021) Symptom evolution in patients with esophageal and gastric cancer receiving palliative chemotherapy: a population-based study. Ann Surg Oncol 28(1):79–87
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献